Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | 1,194,100 | 924,800 |
| Depreciation Amortization | N/A | N/A | N/A | 103,600 | 68,700 |
| Accounts receivable | 1,143,222 | 550,291 | 2,326,310 | 72,200 | 52,500 |
| Accounts payable and accrued liabilities | -932,009 | -507,160 | -1,989,685 | -43,100 | -43,700 |
| Other Working Capital | 176,112 | 38,105 | 251,508 | 287,400 | 223,000 |
| Other Operating Activity | -188,980 | -38,293 | -302,639 | -1,433,715 | -1,107,092 |
| Operating Cash Flow | $198,345 | $42,943 | $285,494 | $180,485 | $118,208 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,673 | 9,522 | -68,695 | -67,716 | -60,043 |
| PPE Investments | -45,757 | -23,555 | -125,510 | -71,678 | -49,797 |
| Net Acquisitions | -16,083 | -16,083 | 7,230 | 7,230 | 7,185 |
| Purchase Sale Intangibles | 7,383 | 7,403 | -3 | -3 | -3 |
| Other Investing Activity | 7,383 | 7,403 | -3 | -3 | -3 |
| Investing Cash Flow | $-37,784 | $-22,713 | $-186,978 | $-132,167 | $-102,658 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | -1,505 |
| Debt Repayment | -359 | -237 | -2,961 | -1,595 | N/A |
| Common Stock Issued | 7,743 | 3,831 | 14,133 | 10,858 | 7,112 |
| Common Stock Repurchased | -15,001 | N/A | -48,912 | N/A | N/A |
| Other Financing Activity | -5,867 | -1,433 | -10,940 | -10,940 | -5,108 |
| Financing Cash Flow | $-13,484 | $2,161 | $-48,680 | $-1,677 | $499 |
| Exchange Rate Effect | 2,127 | 1,982 | -655 | 3,965 | 3,053 |
| Beginning Cash Position | 434,164 | 434,164 | 384,983 | 384,983 | 384,983 |
| End Cash Position | 583,368 | 458,537 | 434,164 | 435,589 | 404,085 |
| Net Cash Flow | $149,204 | $24,373 | $49,181 | $50,606 | $19,102 |
| Free Cash Flow | |||||
| Operating Cash Flow | 198,345 | 42,943 | 285,494 | 180,485 | 118,208 |
| Capital Expenditure | -45,843 | -23,629 | -129,825 | -75,951 | -53,897 |
| Free Cash Flow | 152,502 | 19,314 | 155,669 | 104,534 | 64,311 |